Posttransplant MRD monitoring by TP53 duplex sequencing with APR-246 + azacitidine maintenance predicts outcomes

作者：David A. Sallman, Amy F. McLemore, Rami S. Komrokji, Hany Elmariah, Andrew Kuykendall, Nelli Bejanyan, Onyee Chan, Rawan Faramand, Joseph A. Pidala, Sean Yoder, Lia Perez, Taiga Nishihori, Eric Padron, Hugo F. Fernández, Jeffrey E. Lancet, Asmita Mishra · 发表于：Blood Advances · 年份：2025 · DOI：10.1182/bloodadvances.2025017742 · 被引用次数：2 · 研究领域：Acute Myeloid Leukemia Research、Multiple Myeloma Research and Treatments、Cancer Genomics and Diagnostics